» Articles » PMID: 34485339

Immune System Disequilibrium-Neutrophils, Their Extracellular Traps, and COVID-19-Induced Sepsis

Overview
Specialty General Medicine
Date 2021 Sep 6
PMID 34485339
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Equilibrium within the immune system can often determine the fate of its host. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic. Immune dysregulation remains one of the main pathophysiological components of SARS-CoV-2-associated organ injury, with over-activation of the innate immune system, and induced apoptosis of adaptive immune cells. Here, we provide an overview of the innate immune system, both in general and relating to COVID-19. We specifically discuss "NETosis," the process of neutrophil release of their extracellular traps, which may be a more recently described form of cell death that is different from apoptosis, and how this may propagate organ dysfunction in COVID-19. We complete this review by discussing Stem Cell Therapies in COVID-19 and emerging COVID-19 phenotypes, which may allow for more targeted therapy in the future. Finally, we consider the array of potential therapeutic targets in COVID-19, and associated therapeutics.

Citing Articles

The role of extracellular histones in COVID-19.

de Vries F, Huckriede J, Wichapong K, Reutelingsperger C, Nicolaes G J Intern Med. 2022; 293(3):275-292.

PMID: 36382685 PMC: 10108027. DOI: 10.1111/joim.13585.


Update on Innate Immunity in Acute Kidney Injury-Lessons Taken from COVID-19.

Musial K Int J Mol Sci. 2022; 23(20).

PMID: 36293370 PMC: 9604105. DOI: 10.3390/ijms232012514.


The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Ferrari D, Rubini M, Burns J Front Immunol. 2022; 13:904419.

PMID: 35784277 PMC: 9248768. DOI: 10.3389/fimmu.2022.904419.


Cell-Free DNA, Neutrophil extracellular traps (NETs), and Endothelial Injury in Coronavirus Disease 2019- (COVID-19-) Associated Acute Kidney Injury.

Henry B, de Oliveira M, Cheruiyot I, Benoit J, Rose J, Favaloro E Mediators Inflamm. 2022; 2022:9339411.

PMID: 35497096 PMC: 9054425. DOI: 10.1155/2022/9339411.

References
1.
Mera S, tatulescu D, Cismaru C, Bondor C, Slavcovici A, Zanc V . Multiplex cytokine profiling in patients with sepsis. APMIS. 2011; 119(2):155-63. DOI: 10.1111/j.1600-0463.2010.02705.x. View

2.
Zimmer R, Scherbarth H, Rillo O, Gomez-Reino J, Muller S . Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial. Ann Rheum Dis. 2012; 72(11):1830-5. PMC: 3812851. DOI: 10.1136/annrheumdis-2012-202460. View

3.
Tang B, Huang S, McLean A . Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care. 2010; 14(6):R237. PMC: 3219990. DOI: 10.1186/cc9392. View

4.
Gordon A, Mouncey P, Al-Beidh F, Rowan K, Nichol A, Arabi Y . Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med. 2021; 384(16):1491-1502. PMC: 7953461. DOI: 10.1056/NEJMoa2100433. View

5.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View